| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.56 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |